Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders.

antithrombin (AT) plasminogen activator inhibitor 1 (PAI-1) protease nexin I (PN-1) protein Z-dependent protease inhibitor (ZPI) serpin (serine proteinase inhibitor) therapy

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2020
Historique:
received: 29 10 2020
accepted: 10 12 2020
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 26 1 2021
Statut: epublish

Résumé

Bleeding and thrombotic disorders result from imbalances in coagulation or fibrinolysis, respectively. Inhibitors from the serine protease inhibitor (serpin) family have a key role in regulating these physiological events, and thus stand out as potential therapeutic targets for modulating fibrin clot formation or dismantling. Here, we review the diversity of serpin-targeting strategies in the area of hemostasis, and detail the suggested use of modified serpins and serpin inhibitors (ranging from small-molecule drugs to antibodies) to treat or prevent bleeding or thrombosis.

Identifiants

pubmed: 33490121
doi: 10.3389/fcvm.2020.622778
pmc: PMC7817699
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

622778

Informations de copyright

Copyright © 2021 Bianchini, Auditeau, Razanakolona, Vasse and Borgel.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Thromb Res. 2019 Jul;179:56-63
pubmed: 31078121
Blood. 2008 May 15;111(10):4973-8
pubmed: 18344422
Blood. 2017 Jan 5;129(1):105-113
pubmed: 27789479
Expert Opin Ther Pat. 2013 Jul;23(7):801-15
pubmed: 23521527
Cardiovasc Hematol Agents Med Chem. 2014;12(2):91-125
pubmed: 25374013
Front Biosci (Landmark Ed). 2016 Jun 01;21:1372-92
pubmed: 27100512
Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62
pubmed: 6035483
Int J Biochem Cell Biol. 2004 Mar;36(3):386-9
pubmed: 14687916
Hematol Oncol Clin North Am. 2007 Feb;21(1):1-11
pubmed: 17258114
J Clin Invest. 1998 Oct 15;102(8):1481-8
pubmed: 9788960
Blood. 2000 Nov 1;96(9):3049-55
pubmed: 11049983
Blood Rev. 2020 Jan;39:100618
pubmed: 31676141
EMBO Mol Med. 2020 Apr 7;12(4):e11298
pubmed: 32159286
J Thromb Haemost. 2003 Jul;1(7):1535-49
pubmed: 12871289
Sci Rep. 2016 Nov 23;6:36462
pubmed: 27876785
J Cereb Blood Flow Metab. 2010 May;30(5):904-12
pubmed: 20087372
Thromb Res. 2012 Oct;130(4):576-85
pubmed: 22801256
Chest. 2008 Jun;133(6 Suppl):141S-159S
pubmed: 18574264
Blood. 2010 Jan 7;115(1):97-106
pubmed: 19855083
Cardiovasc Drug Rev. 2002 Winter;20(1):37-52
pubmed: 12070533
Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):454-60
pubmed: 17194895
J Thromb Haemost. 2020 Sep;18(9):2155-2168
pubmed: 32495984
FEBS J. 2005 Oct;272(19):4842-51
pubmed: 16176258
Blood. 2011 Feb 10;117(6):2054-60
pubmed: 21048158
Thromb Haemost. 1996 Dec;76(6):983-8
pubmed: 8972021
Thromb Haemost. 2020 Sep 28;:
pubmed: 32987444
Br J Haematol. 2007 Apr;137(2):99-108
pubmed: 17391489
J Thromb Haemost. 2007 Jul;5 Suppl 1:102-15
pubmed: 17635716
Biochimie. 2010 Nov;92(11):1587-96
pubmed: 20685328
J Thromb Haemost. 2019 Jan;17(1):149-156
pubmed: 30451376
J Thromb Haemost. 2019 Oct;17(10):1655-1660
pubmed: 31423718
Thromb Haemost. 2016 Aug 30;116(3):452-60
pubmed: 27412396
N Engl J Med. 2017 Aug 31;377(9):819-828
pubmed: 28691885
J Clin Invest. 2000 Oct;106(7):873-8
pubmed: 11018075
Br J Haematol. 2018 Mar;180(5):715-720
pubmed: 29363751
J Med Chem. 2004 Jul 1;47(14):3491-4
pubmed: 15214776
J Thromb Haemost. 2018 May 20;:
pubmed: 29779246
Thromb Res. 2012 Apr;129(4):407-17
pubmed: 22133273
Thromb Res. 2015 May;135(5):923-32
pubmed: 25784135
Drug Discov Today. 2014 Sep;19(9):1476-82
pubmed: 24886765
Nature. 2000 Oct 19;407(6806):923-6
pubmed: 11057674
J Blood Med. 2018 Aug 22;9:135-140
pubmed: 30174468
Exp Mol Med. 2020 Mar;52(3):367-379
pubmed: 32152451
Eur J Med Chem. 2015 Mar 6;92:619-36
pubmed: 25615797
Chest. 2003 Sep;124(3 Suppl):26S-32S
pubmed: 12970121
Chem Rev. 2002 Dec;102(12):4751-804
pubmed: 12475206
J Biol Chem. 2009 Jul 31;284(31):20441-5
pubmed: 19401470
Biochem Biophys Res Commun. 1983 Oct 31;116(2):492-9
pubmed: 6651824
Blood. 2019 Nov 7;134(19):1632-1644
pubmed: 31383642
Blood. 2008 May 15;111(10):4871-9
pubmed: 18309033

Auteurs

Elsa P Bianchini (EP)

HITh, UMR_S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Claire Auditeau (C)

HITh, UMR_S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Mahita Razanakolona (M)

HITh, UMR_S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Marc Vasse (M)

HITh, UMR_S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Service de Biologie Clinique, Hôpital Foch, Suresnes, France.

Delphine Borgel (D)

HITh, UMR_S1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Laboratoire d'Hématologie Biologique, Hôpital Necker, APHP, Paris, France.

Classifications MeSH